Chao Hu, Chen Chen, Xiaolu Yu, Zhiying Li, Feng Tang, Qi Sun, Yiru Long, Likun Gong. Non-blocking anti-PD-L1 nanobody conjugated to TLR7 agonist mediates macrophage/NK cell-associated antitumor effectsJ. Acta Pharmaceutica Sinica B, 2025, 15(7): 3819-3823. DOI: 10.1016/j.apsb.2025.05.005
|
Citation:
|
Chao Hu, Chen Chen, Xiaolu Yu, Zhiying Li, Feng Tang, Qi Sun, Yiru Long, Likun Gong. Non-blocking anti-PD-L1 nanobody conjugated to TLR7 agonist mediates macrophage/NK cell-associated antitumor effectsJ. Acta Pharmaceutica Sinica B, 2025, 15(7): 3819-3823. DOI: 10.1016/j.apsb.2025.05.005
|
Chao Hu, Chen Chen, Xiaolu Yu, Zhiying Li, Feng Tang, Qi Sun, Yiru Long, Likun Gong. Non-blocking anti-PD-L1 nanobody conjugated to TLR7 agonist mediates macrophage/NK cell-associated antitumor effectsJ. Acta Pharmaceutica Sinica B, 2025, 15(7): 3819-3823. DOI: 10.1016/j.apsb.2025.05.005
|
Citation:
|
Chao Hu, Chen Chen, Xiaolu Yu, Zhiying Li, Feng Tang, Qi Sun, Yiru Long, Likun Gong. Non-blocking anti-PD-L1 nanobody conjugated to TLR7 agonist mediates macrophage/NK cell-associated antitumor effectsJ. Acta Pharmaceutica Sinica B, 2025, 15(7): 3819-3823. DOI: 10.1016/j.apsb.2025.05.005
|